Literature DB >> 28138864

Refractory ITP in a patient with Kabuki syndrome: response to low-dose rituximab.

Brian Kerr1, Philip Murphy2, John Quinn2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28138864     DOI： 10.1007/s12185-016-2176-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  11 in total

1.  MLL2 and KDM6A mutations in patients with Kabuki syndrome.

Authors:  Noriko Miyake; Eriko Koshimizu; Nobuhiko Okamoto; Seiji Mizuno; Tsutomu Ogata; Toshiro Nagai; Tomoki Kosho; Hirofumi Ohashi; Mitsuhiro Kato; Goro Sasaki; Hiroyo Mabe; Yoriko Watanabe; Makoto Yoshino; Toyojiro Matsuishi; Jun-ichi Takanashi; Vorasuk Shotelersuk; Mustafa Tekin; Nobuhiko Ochi; Masaya Kubota; Naoko Ito; Kenji Ihara; Toshiro Hara; Hidefumi Tonoki; Tohru Ohta; Kayoko Saito; Mari Matsuo; Mari Urano; Takashi Enokizono; Astushi Sato; Hiroyuki Tanaka; Atsushi Ogawa; Takako Fujita; Yoko Hiraki; Sachiko Kitanaka; Yoichi Matsubara; Toshio Makita; Masataka Taguri; Mitsuko Nakashima; Yoshinori Tsurusaki; Hirotomo Saitsu; Ko-ichiro Yoshiura; Naomichi Matsumoto; Norio Niikawa
Journal:  Am J Med Genet A       Date:  2013-08-02       Impact factor: 2.802

2.  Low-dose rituximab in adult patients with primary immune thrombocytopenia.

Authors:  Francesco Zaja; Nicola Vianelli; Stefano Volpetti; Marta Lisa Battista; Marzia Defina; Salvatore Palmieri; Monica Bocchia; Marta Medeot; Stefano De Luca; Felicetto Ferrara; Miriam Isola; Michele Baccarani; Renato Fanin
Journal:  Eur J Haematol       Date:  2010-07-28       Impact factor: 2.997

Review 3.  Immune abnormalities are a frequent manifestation of Kabuki syndrome.

Authors:  Jodi D Hoffman; Karen L Ciprero; Kathleen E Sullivan; Paige B Kaplan; Donna M McDonald-McGinn; Elaine H Zackai; Jeffrey E Ming
Journal:  Am J Med Genet A       Date:  2005-06-15       Impact factor: 2.802

4.  Phenotypic spectrum and management issues in Kabuki syndrome.

Authors:  H Kawame; M C Hannibal; L Hudgins; R A Pagon
Journal:  J Pediatr       Date:  1999-04       Impact factor: 4.406

5.  Autoimmune disorders in Kabuki syndrome.

Authors:  Jeffrey E Ming; Karen L Russell; Donna M McDonald-McGinn; Elaine H Zackai
Journal:  Am J Med Genet A       Date:  2005-01-30       Impact factor: 2.802

Review 6.  Kabuki syndrome: a review.

Authors:  M P Adam; L Hudgins
Journal:  Clin Genet       Date:  2005-03       Impact factor: 4.438

7.  Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab.

Authors:  Roberto Stasi; Nichola Cooper; Giovanni Del Poeta; Elisa Stipa; Maria Laura Evangelista; Elisabetta Abruzzese; Sergio Amadori
Journal:  Blood       Date:  2008-03-28       Impact factor: 22.113

8.  Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults.

Authors:  Drew Provan; Tom Butler; Maria Laura Evangelista; Sergio Amadori; Adrian C Newland; Roberto Stasi
Journal:  Haematologica       Date:  2007-12       Impact factor: 9.941

9.  Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura.

Authors:  Roberto Stasi; Giovanni Del Poeta; Elisa Stipa; Maria Laura Evangelista; Margherita M Trawinska; Nichola Cooper; Sergio Amadori
Journal:  Blood       Date:  2007-06-04       Impact factor: 22.113

10.  Autoimmune haematological disorders in two Italian children with Kabuki syndrome.

Authors:  Paola Giordano; Giuseppe Lassandro; Maria Sangerardi; Maria Felicia Faienza; Federica Valente; Baldassarre Martire
Journal:  Ital J Pediatr       Date:  2014-01-25       Impact factor: 2.638
View more
  1 in total

1.  Progressive Massive Splenomegaly in an Adult Patient with Kabuki Syndrome Complicated with Immune Thrombocytopenic Purpura.

Authors:  Toshiki Mushino; Takayuki Hiroi; Yusuke Yamashita; Norihiko Suzaki; Hiroyuki Mishima; Masaki Ueno; Akira Kinoshita; Koichi Minami; Kohsuke Imai; Ko-Ichiro Yoshiura; Takashi Sonoki; Shinobu Tamura
Journal:  Intern Med       Date:  2021-02-01       Impact factor: 1.271
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.